Ansell reported $769M in Ordinary Share Capital for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Ansell ANN:AU $ 769M 37M
Australian Pharma API:AU $ 566.46M 0
Cochlear COH:AU $ 1.28B 400K
Estia Health EHE:AU $ 803.46M 0
GUD GUD:AU $ 195.56M 5.72M
Healius Ltd HLS:AU $ 2.58B 97.4M
Integral Diagnostics Ltd IDX:AU 219.22M 192K
Japara Healthcare JHC:AU 524.66M 0
Mayne Pharma MYX:AU $ 1.24B 47K
Nanosonics Ltd NAN:AU $ 113.54M 164K
Next Science Ltd NXS:AU 102.92M 1.64M
Polynovo Ltd PNV:AU 139.25M 180K
Ramsay Health Care RHC:AU $ 2.2B 0
Regis Healthcare REG:AU 273.52M 0
ResMed RMD:AU $ 583K 1000
Sigma Healthcare Ltd SIG:AU 1.22B 2.01M
Somnomed Ltd SOM:AU 74.26M 261.25K
Sonic Healthcare SHL:AU $ 4.08B 3.93M